Resource Center: Special populations, Just became waivered
Results 1 - 10 of 39
Search Results
Description:
This journal article compares the effectiveness of detoxification vs. continuing buprenorphine-naloxone therapy for treating opioid-addicted adolescents. The study followed 152 patients between the ages of 15 and 21 who were randomly selected to receive either a 12-week buprenorphone-naloxone program, or a 14-day taper.
Source:
The Journal of the American Medical Association (JAMA) 4.5
Your rating: None Average: 4.5 (2 votes)
Tags:
Description:
This information brief discusses the abuse of prescription drugs by young people, commonly abused prescription drugs, and diversion of said drugs.
Source:
National Drug Intelligence Center 0
Your rating: None
Tags:
Description:
Discusses the prevalence and effects of common combinations of polysubstance abuse in opioid addicts.
Source:
Substance Abuse and Mental Health Association (SAMHSA) 4.666665
Your rating: None Average: 4.7 (3 votes)
Tags:
Description:
This chapter of TIP 43 is aimed to help treatment providers identify co-occurring medical problems in patients who are addicted to opioids.
Source:
Substance Abuse and Mental Health Association (SAMHSA) 4.333335
Your rating: None Average: 4.3 (3 votes)
Tags:
Description:
This chapter of TIP 43 discusses the prevalence, etiology, screening, diagnosis, and treatment of psychiatric disorders that co-occur with opioid addiction.
Source:
Substance Abuse and Mental Health Services Administration (SAMHSA) 4.666665
Your rating: None Average: 4.7 (3 votes)
Tags:
Description:
The TIP 32 aims to help treatment providers design and deliver better services to adolescent clients with substance use disorders.
Source:
Substance Abuse and Mental Health Services Administration (SAMHSA) 4.333335
Your rating: None Average: 4.3 (3 votes)
Tags:
Description:
Guideline document designed to aid treatment providers deliver better services to elderly patients with substance use disorders.
Source:
Substance Abuse and Mental Health Services Administration (SAMHSA) 4.333335
Your rating: None Average: 4.3 (3 votes)
Tags:
Description:
Provides physicians with information on how to work with a patient who has co-occurring disorders, including how to engage the patient in treatment and how to develop a successful therapeutic relationship.
Source:
Substance Abuse and Mental Health Services Administration (SAMHSA) 4.333335
Your rating: None Average: 4.3 (3 votes)
Tags:
Description:
This chapter provides information on using buprenorphine in patients who have special circumstances, including patients who have comorbid medical conditions or pain, pregnant patients, and adolescents.
Source:
Substance Abuse and Mental Health Services Administration (SAMHSA) 4.666665
Your rating: None Average: 4.7 (3 votes)
Tags:
Description:
Offers recommendations for screening and assessment of adolescents as and discusses referrals, legal issues, and the juvenile justice system.
Source:
Substance Abuse and Mental Health Services Administration (SAMHSA) 4.5
Your rating: None Average: 4.5 (4 votes)
Tags:
- Home
- Training/CME
- Resources
- How-To Guides
- All How-To Guides
- Get Started Prescribing Buprenorphine
- Assess and Treat Patients with Comorbid Health Issues
- Conduct Buprenorphine Induction
- Establish and Manage a Buprenorphine Practice
- Manage Challenging Patients
- Comply with Rules, Regulations, and Recordkeeping
- Understand Insurance and Billing Issues
- Screen for Substance Abuse
- Refer Patients to an Addiction Specialist
- Review: What is Buprenorphine?
- Your Bup Site!
Refine your results
Click a term to refine your current search.
Topics
: all » Special populationsCommonly Used Forms
Patient Handouts
- Pregnancy (2)
- En Español (1)
Physician stage in practice
: all » Just became waiveredResource Type
Tags
- Addiction (12)
- Adolescents (9)
- Assessment (7)
- Behavioral therapy (1)
- Comorbidities (9)
- Complicated patients (11)
- Complications (1)
- Consent (3)
- Contract (1)
- Cost of treatment (1)
- Dependence (8)
- Detoxification (2)
- Diagnosis (3)
- Discontinuation (2)
- Dosing (4)
- Drug interactions (3)
- DSM (1)
- Elderly patients (3)
- Expert panel (1)
- Hepatitis (4)
- Heroin (1)
- HIV/AIDS (4)
- Induction (3)
- Locator (2)
- Maintenance (4)
- Methadone (5)
- Older adults (2)
- Overdose (1)
- Oxycodone (2)
- Pain (8)
- Pharmacology (4)
- Pharmacotherapy (1)
- Pharmacy (1)
- Polysubstance use (4)
- Precautions (4)
- Pregnant (5)
- Psychiatric (3)
- Psychosocial (2)
- Referral (1)
- Relapse (3)
- Risk factors (1)
- Rural (3)
- Screening (5)
- Side effects (2)
- Special populations (32)
- Suboxone (6)
- Symptoms (1)
- Tapering (1)
- Tolerance (1)
- Withdrawal (4)

